Congress is facing pressure from outside groups to consider legislation to reform the pharmacy benefit manager (PBM) industry during the lame duck period. PBM reforms have bipartisan backing ...

After hours: November 29 at 4:42 PM EST Loading Chart for PBM ...

LAME-DUCK PBM UPDATE — Lawmakers pushing to regulate pharmacy benefit managers’ business practices face headwinds in this Congress’ final weeks. The pharmaceutical industry, along with ...

Total Current Assets 86.07 87.77 103.35 83.88 ...

In a recent conversation with Greg Baker, CEO of AffirmedRx, the PBM professional outlined the company’s distinct approach in the PBM industry with MHE editors. In a recent conversation with Greg ...

Gain( Loss)on Saleof Assets -4.72 0.00 0.13 ...

PhRMA is pushing to get pharmacy benefit manager (PBM) reform over the line in Congress’ lame-duck session, using its first TV spot since the U.S. election to rail against a familiar ...

Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) policies, how they impact biosimilar accessibility, and how addressing these ...

CVS Caremark—the largest PBM in the U.S.—removed Humira from most of its commercial lists of reimbursable drugs starting April 1. In its place, the PBM included the Humira-referenced ...

One lawmaker who has been deeply critical of the PBM sector, Rep Earl L. “Buddy” Carter (R-GA), who is a pharmacist by trade, welcomed the report and its findings. “Since day one in Congress ...

Kemp spokesperson Garrison Douglas said, “The governor remains entirely and wholeheartedly supportive of Georgia’s independent pharmacists and the need for PBM transparency.” In his veto message, Kemp ...